| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
19.13(B) |
| Last
Volume: |
2,238,021 |
Avg
Vol: |
1,171,182 |
| 52
Week Range: |
$120.62 - $144.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 724 |
| Guru Rank Value : 1.3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,760 |
18,097 |
18,097 |
100,860 |
| Total Sell Value |
$246,400 |
$2,309,019 |
$2,309,019 |
$14,306,288 |
| Total People Sold |
1 |
4 |
4 |
6 |
| Total Sell Transactions |
1 |
7 |
7 |
21 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Prevoznik Michael E |
SVP & General Counsel |
• – – |
2020-02-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
480 |
38,978 |
|
- |
|
| Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
• – – |
2020-01-02 |
4 |
D |
$106.52 |
$164,360 |
D/D |
(1,543) |
21,250 |
|
- |
|
| Davis J. E. |
EVP, General Diagnostics |
• – – |
2020-01-02 |
4 |
AS |
$105.45 |
$15,153,864 |
D/D |
(143,537) |
36,543 |
|
4% |
|
| Davis J. E. |
EVP, General Diagnostics |
• – – |
2020-01-02 |
4 |
OE |
$66.51 |
$9,853,318 |
D/D |
143,546 |
180,080 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2019-11-27 |
4 |
S |
$107.15 |
$4,786,564 |
D/D |
(44,556) |
39,458 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2019-11-27 |
4 |
OE |
$52.17 |
$2,453,565 |
D/D |
44,556 |
84,014 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2019-09-17 |
4 |
AS |
$106.00 |
$530,000 |
D/D |
(5,000) |
23,732 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2019-09-17 |
4 |
OE |
$55.65 |
$278,250 |
D/D |
5,000 |
28,671 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2019-06-13 |
4 |
S |
$100.00 |
$7,300,500 |
D/D |
(73,005) |
66,017 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2019-06-13 |
4 |
OE |
$52.17 |
$3,808,306 |
D/D |
73,005 |
139,022 |
|
- |
|
| Rusckowski Stephen H |
Chairman, President and CEO |
• • – |
2019-06-13 |
4 |
S |
$100.00 |
$24,456,500 |
D/D |
(244,565) |
213,049 |
|
- |
|
| Rusckowski Stephen H |
Chairman, President and CEO |
• • – |
2019-06-13 |
4 |
OE |
$52.17 |
$12,757,733 |
D/D |
244,565 |
457,614 |
|
- |
|
| Morrison Denise M |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
2,212 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
14,951 |
|
- |
|
| Stanzione Daniel |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
38,041 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
12,125 |
|
- |
|
| Main Timothy L |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
18,057 |
|
- |
|
| Torley Helen |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
3,366 |
|
- |
|
| Pfeiffer Gary M |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
19,563 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,722 |
18,576 |
|
- |
|
| Davis J. E. |
EVP, General Diagnostics |
• – – |
2019-04-08 |
4 |
AS |
$90.15 |
$722,332 |
D/D |
(8,000) |
36,534 |
|
- |
|
| Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
• – – |
2019-04-04 |
4 |
AS |
$90.59 |
$6,013,739 |
D/D |
(66,382) |
67,526 |
|
- |
|
| Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
• – – |
2019-04-04 |
4 |
OE |
$71.17 |
$4,305,216 |
D/D |
60,492 |
133,908 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAOOffi |
• – – |
2019-04-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
615 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAOOffi |
• – – |
2019-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,558 |
|
- |
|
787 Records found
|
|
Page 15 of 32 |
|
|
2.64 (1.89%) 
